Literature DB >> 29375987

A novel mutation in PRPF31, causative of autosomal dominant retinitis pigmentosa, using the BGISEQ-500 sequencer.

Yu Zheng1,2,3, Hai-Lin Wang4, Jian-Kang Li2,3, Li Xu4, Laurent Tellier2,3, Xiao-Lin Li4, Xiao-Yan Huang1,2,3, Wei Li2,3, Tong-Tong Niu4, Huan-Ming Yang2,5, Jian-Guo Zhang2,3, Dong-Ning Liu4.   

Abstract

AIM: To study the genes responsible for retinitis pigmentosa.
METHODS: A total of 15 Chinese families with retinitis pigmentosa, containing 94 sporadically afflicted cases, were recruited. The targeted sequences were captured using the Target_Eye_365_V3 chip and sequenced using the BGISEQ-500 sequencer, according to the manufacturer's instructions. Data were aligned to UCSC Genome Browser build hg19, using the Burroughs Wheeler Aligner MEM algorithm. Local realignment was performed with the Genome Analysis Toolkit (GATK v.3.3.0) IndelRealigner, and variants were called with the Genome Analysis Toolkit Haplotypecaller, without any use of imputation. Variants were filtered against a panel derived from 1000 Genomes Project, 1000G_ASN, ESP6500, ExAC and dbSNP138. In all members of Family ONE and Family TWO with available DNA samples, the genetic variant was validated using Sanger sequencing.
RESULTS: A novel, pathogenic variant of retinitis pigmentosa, c.357_358delAA (p.Ser119SerfsX5) was identified in PRPF31 in 2 of 15 autosomal-dominant retinitis pigmentosa (ADRP) families, as well as in one, sporadic case. Sanger sequencing was performed upon probands, as well as upon other family members. This novel, pathogenic genotype co-segregated with retinitis pigmentosa phenotype in these two families.
CONCLUSION: ADRP is a subtype of retinitis pigmentosa, defined by its genotype, which accounts for 20%-40% of the retinitis pigmentosa patients. Our study thus expands the spectrum of PRPF31 mutations known to occur in ADRP, and provides further demonstration of the applicability of the BGISEQ500 sequencer for genomics research.

Entities:  

Keywords:  BGISEQ-500; PRPF31; retinitis pigmentosa

Year:  2018        PMID: 29375987      PMCID: PMC5767654          DOI: 10.18240/ijo.2018.01.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

1.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 2.  Variant haploinsufficiency and phenotypic non-penetrance in PRPF31-associated retinitis pigmentosa.

Authors:  A M Rose; S S Bhattacharya
Journal:  Clin Genet       Date:  2016-03-04       Impact factor: 4.438

3.  Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations.

Authors:  Carlo Rivolta; Terri L McGee; Thomas Rio Frio; Roderick V Jensen; Eliot L Berson; Thaddeus P Dryja
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

Review 4.  Autosomal dominant retinitis pigmentosa secondary to pre-mRNA splicing-factor gene PRPF31 (RP11): review of disease mechanism and report of a family with a novel 3-base pair insertion.

Authors:  Virginia M Utz; Craig D Beight; Meghan J Marino; Stephanie A Hagstrom; Elias I Traboulsi
Journal:  Ophthalmic Genet       Date:  2013-01-23       Impact factor: 1.803

Review 5.  Alternative splicing and retinal degeneration.

Authors:  M M Liu; D J Zack
Journal:  Clin Genet       Date:  2013-06-05       Impact factor: 4.438

6.  Dominant PRPF31 mutations are hypostatic to a recessive CNOT3 polymorphism in retinitis pigmentosa: a novel phenomenon of "linked trans-acting epistasis".

Authors:  Anna M Rose; Amna Z Shah; Giulia Venturini; Carlo Rivolta; Geoffrey E Rose; Shomi S Bhattacharya
Journal:  Ann Hum Genet       Date:  2013-10-14       Impact factor: 1.670

7.  Transcriptional regulation of PRPF31 gene expression by MSR1 repeat elements causes incomplete penetrance in retinitis pigmentosa.

Authors:  Anna M Rose; Amna Z Shah; Giulia Venturini; Abhay Krishna; Aravinda Chakravarti; Carlo Rivolta; Shomi S Bhattacharya
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

Review 8.  Mutations in spliceosomal proteins and retina degeneration.

Authors:  Šárka Růžičková; David Staněk
Journal:  RNA Biol       Date:  2016-06-14       Impact factor: 4.652

9.  Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients.

Authors:  Fei Xu; Ruifang Sui; Xiaofang Liang; Hui Li; Ruxin Jiang; Fangtian Dong
Journal:  Mol Vis       Date:  2012-12-14       Impact factor: 2.367

Review 10.  Genes and mutations causing retinitis pigmentosa.

Authors:  S P Daiger; L S Sullivan; S J Bowne
Journal:  Clin Genet       Date:  2013-06-19       Impact factor: 4.438

View more
  4 in total

1.  A novel mutation in the PRPF31 in a North Indian adRP family with incomplete penetrance.

Authors:  Sofia Bhatia; Shiwali Goyal; Indu R Singh; Daljit Singh; Vanita Vanita
Journal:  Doc Ophthalmol       Date:  2018-08-11       Impact factor: 2.379

2.  Genomic variants identified from whole-genome resequencing of indicine cattle breeds from Pakistan.

Authors:  Naveed Iqbal; Xin Liu; Ting Yang; Ziheng Huang; Quratulain Hanif; Muhammad Asif; Qaiser Mahmood Khan; Shahid Mansoor
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

Review 3.  Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy.

Authors:  Gabrielle Wheway; Andrew Douglas; Diana Baralle; Elsa Guillot
Journal:  Exp Eye Res       Date:  2020-01-31       Impact factor: 3.467

Review 4.  Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium.

Authors:  Debra A Thompson; Alessandro Iannaccone; Robin R Ali; Vadim Y Arshavsky; Isabelle Audo; James W B Bainbridge; Cagri G Besirli; David G Birch; Kari E Branham; Artur V Cideciyan; Steven P Daiger; Deniz Dalkara; Jacque L Duncan; Abigail T Fahim; John G Flannery; Roberto Gattegna; John R Heckenlively; Elise Heon; K Thiran Jayasundera; Naheed W Khan; Henry Klassen; Bart P Leroy; Robert S Molday; David C Musch; Mark E Pennesi; Simon M Petersen-Jones; Eric A Pierce; Rajesh C Rao; Thomas A Reh; Jose A Sahel; Dror Sharon; Paul A Sieving; Enrica Strettoi; Paul Yang; David N Zacks
Journal:  Transl Vis Sci Technol       Date:  2020-06-03       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.